Showing results (231-240 of 511) with videos related to

Sort By:
Pageof 52
Cancer Research|July 31, 2014
Genetic ablation of metadherin inhibits autochthonous prostate cancer progression and metastasisLiling Wan, Guohong Hu, Yong Wei, et al.
Endocrinology|January 8, 2005
Bone turnover mediates preferential localization of prostate cancer in the skeletonAbraham Schneider, Linda M Kalikin, Ana C Mattos, et al.
The Prostate|March 10, 2018
PBOV1 as a potential biomarker for more advanced prostate cancer based on protein and digital histomorphometric analysisNeil M Carleton, Guangjing Zhu, Mikhail Gorbounov, et al.
Oncotarget|May 7, 2015
OVOL guides the epithelial-hybrid-mesenchymal transitionDongya Jia, Mohit Kumar Jolly, Marcelo Boareto, et al.
PET Clinics|October 13, 2022
18F-Labeled Radiotracers for Prostate-specific Membrane Antigen: Historical Perspective and Future DirectionsSteven P Rowe, Ali Salavati, Rudolf A Werner, et al.
Seminars in Nuclear Medicine|June 23, 2019
Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging of Prostate Cancer: An Update on Important PitfallsSara Sheikhbahaei, Rudolf A Werner, Lilja B Solnes, et al.
Neoplasia (New York, N.Y.)|August 8, 2022
Targeting interleukin 4 receptor alpha on tumor-associated macrophages reduces the pro-tumor macrophage phenotypeAmber E de Groot, Kayla V Myers, Timothy E G Krueger, et al.
Medical Oncology (Northwood, London, England)|August 29, 2023
Targeting MerTK decreases efferocytosis and increases anti-tumor immune infiltrate in prostate cancerKayla V Myers Chen, Amber E de Groot, Sabrina A Mendez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 8, 2010
Inherited variants in the chemokine CCL2 gene and prostate cancer aggressiveness in a Caucasian cohortTong Sun, Lee Gwo-Shu Mary, William K Oh, et al.
Pageof 52